| 000 | 01751 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513140955.0 | ||
| 264 | 0 | _c19980407 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(14)71128-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDell, S J | |
| 245 | 0 | 0 |
_aA controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cJun 1997 |
||
| 300 |
_a791-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostadienes _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aConjunctivitis, Allergic _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aLoteprednol Etabonate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 |
_aPollen _xadverse effects |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aSeasons |
| 700 | 1 | _aShulman, D G | |
| 700 | 1 | _aLowry, G M | |
| 700 | 1 | _aHowes, J | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 123 _gno. 6 _gp. 791-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(14)71128-6 _zAvailable from publisher's website |
| 999 |
_c9503208 _d9503208 |
||